QTRX Stock Analysis: Buy, Sell, or Hold?
QTRX - Quanterix Corporation Common Stock
$2.83
0.08 (2.73%)
β²
5d:
-16.91%
30d:
-14.39%
90d:
-53.61%
WAIT
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 12, 2026
TODAY
Get Alerted When QTRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called QTRX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: QTRX is down 16.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: QTRX is down 16.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: QTRX is currently trading at $2.83, which is considered oversold relative to its 30-day fair value range of $3.12 to $3.55.
Technical Outlook: Technically, QTRX is in a strong downtrend. Immediate support is located at $2.56, while resistance sits at $3.59.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.33 (+88.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QTRX is in a strong downtrend. Immediate support is located at $2.56, while resistance sits at $3.59.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.33 (+88.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.12 -
$3.55
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 88.8% below Wall St target ($5.33)
- WARNING: Recommendation downgraded due to -16.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$3.12 -
$3.55
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.56
Resistance Level
$3.59
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.86
Wall Street Target
$5.33
(+88.8%)
Revenue Growth (YoY)
24.7%
Profit Margin
-77.1%
Share & Embed Analysis
Last updated: May 11, 2026 7:08 AM ET
Data refreshes hourly during market hours. Next update: 8:08 AM
Data refreshes hourly during market hours. Next update: 8:08 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QTRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 53 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 56 HOLD |